Literature DB >> 19923850

Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles.

Linsey C Phillips1, Alexander L Klibanov, Douglas K Bowles, Michael Ragosta, John A Hossack, Brian R Wamhoff.   

Abstract

BACKGROUND: Safety concerns associated with drug-eluting stents have spurred interest in alternative vessel therapeutics following angioplasty. Microbubble contrast agents have been shown to increase gene transfection in vivo in the presence of ultrasound. OBJECTIVES/
METHODS: The purpose of this study was to determine whether an intravascular ultrasound (IVUS) catheter could mediate plasmid DNA transfection from microbubble carriers to the porcine coronary artery wall following balloon angioplasty.
RESULTS: In the presence of plasmid-coupled microbubbles in vitro only cells exposed to ultrasound from the modified IVUS catheter significantly expressed the transgene. A porcine left anterior descending coronary artery underwent balloon angioplasty followed by injection and insonation of microbubbles from the IVUS catheter at the site of angioplasty. After 3 days, an approximately 6.5-fold increase in transgene expression was observed in arteries that received microbubbles and IVUS compared to those that received microbubbles with no IVUS.
CONCLUSIONS: The results of this study demonstrate for the first time that IVUS is required to enhance gene transfection from microbubble carriers to the vessel wall in vivo. This technology may be applied to both drug and gene therapy to reduce vessel restenosis. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923850      PMCID: PMC2865392          DOI: 10.1159/000258905

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  10 in total

1.  Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles.

Authors:  Jonathan P Christiansen; Brent A French; Alexander L Klibanov; Sanjiv Kaul; Jonathan R Lindner
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

2.  Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.

Authors:  Naotaka Hashiya; Motokuni Aoki; Katsuro Tachibana; Yoshiaki Taniyama; Keita Yamasaki; Kazuya Hiraoka; Hirofumi Makino; Kaneda Yasufumi; Toshio Ogihara; Ryuichi Morishita
Journal:  Biochem Biophys Res Commun       Date:  2004-04-30       Impact factor: 3.575

3.  Spatial and acoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound.

Authors:  Ahad A Rahim; Sarah L Taylor; Nigel L Bush; Gail R ter Haar; Jeffrey C Bamber; Colin D Porter
Journal:  J Gene Med       Date:  2006-11       Impact factor: 4.565

Review 4.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery.

Authors:  Katherine Ferrara; Rachel Pollard; Mark Borden
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

5.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

Authors:  Matthias Pfisterer; Hans Peter Brunner-La Rocca; Peter T Buser; Peter Rickenbacher; Patrick Hunziker; Christian Mueller; Raban Jeger; Franziska Bader; Stefan Osswald; Christoph Kaiser
Journal:  J Am Coll Cardiol       Date:  2006-11-02       Impact factor: 24.094

Review 6.  Ultrasonic gene and drug delivery to the cardiovascular system.

Authors:  Christian R Mayer; Raffi Bekeredjian
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

7.  Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

Authors:  Eric L Eisenstein; Kevin J Anstrom; David F Kong; Linda K Shaw; Robert H Tuttle; Daniel B Mark; Judith M Kramer; Robert A Harrington; David B Matchar; David E Kandzari; Eric D Peterson; Kevin A Schulman; Robert M Califf
Journal:  JAMA       Date:  2006-12-05       Impact factor: 56.272

8.  Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression.

Authors:  M Aikawa; Y Sakomura; M Ueda; K Kimura; I Manabe; S Ishiwata; N Komiyama; H Yamaguchi; Y Yazaki; R Nagai
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

9.  Targeted vascular delivery of antisense molecules using intravenous microbubbles.

Authors:  Thomas R Porter; Feng Xie; Derek Knapp; Patrick Iversen; Luis A Marky; Jeane M Tsutsui; Souvik Maiti; John Lof; Stanley J Radio; Nicholas Kipshidze
Journal:  Cardiovasc Revasc Med       Date:  2006 Jan-Mar

10.  Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis.

Authors:  D L Tharp; B R Wamhoff; H Wulff; G Raman; A Cheong; D K Bowles
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-28       Impact factor: 8.311

  10 in total
  22 in total

Review 1.  Leveraging the power of ultrasound for therapeutic design and optimization.

Authors:  Charles F Caskey; Xiaowen Hu; Katherine W Ferrara
Journal:  J Control Release       Date:  2011-07-30       Impact factor: 9.776

Review 2.  Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.

Authors:  Anthony Wayne Orr; Nicole E Hastings; Brett R Blackman; Brian R Wamhoff
Journal:  J Vasc Res       Date:  2009-10-22       Impact factor: 1.934

3.  An IVUS transducer for microbubble therapies.

Authors:  Joseph P Kilroy; Abhay V Patil; Joshua J Rychak; John A Hossack
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2014-03       Impact factor: 2.725

4.  Micro-ultrasound for preclinical imaging.

Authors:  F Stuart Foster; John Hossack; S Lee Adamson
Journal:  Interface Focus       Date:  2011-06-08       Impact factor: 3.906

5.  Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles.

Authors:  Caitlin W Burke; Jung Soo Suk; Anthony J Kim; Yu-Han J Hsiang; Alexander L Klibanov; Justin Hanes; Richard J Price
Journal:  J Control Release       Date:  2012-07-16       Impact factor: 9.776

Review 6.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.

Authors:  Natalya Rapoport
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-06-22

Review 7.  Phase-shift, stimuli-responsive drug carriers for targeted delivery.

Authors:  Brian E O'Neill; Natalya Rapoport
Journal:  Ther Deliv       Date:  2011-09

8.  Intravascular ultrasound catheter to enhance microbubble-based drug delivery via acoustic radiation force.

Authors:  Joseph P Kilroy; Alexander L Klibanov; Brian R Wamhoff; John A Hossack
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2012-10       Impact factor: 2.725

9.  Acoustic radiation force for vascular cell therapy: in vitro validation.

Authors:  Mehmet Kaya; Catalin Toma; Jianjun Wang; Michelle Grata; Huili Fu; Flordeliza S Villanueva; Xucai Chen
Journal:  Ultrasound Med Biol       Date:  2012-09-10       Impact factor: 2.998

10.  Focused ultrasound-mediated drug delivery from microbubbles reduces drug dose necessary for therapeutic effect on neointima formation--brief report.

Authors:  Linsey C Phillips; Ali H Dhanaliwala; Alexander L Klibanov; John A Hossack; Brian R Wamhoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-29       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.